- Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
- Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
- Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
- Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
More ▼
Key statistics
As of last trade, Enanta Pharmaceuticals Inc (ENTA:NSQ) traded at 17.67, 118.63% above the 52 week low of 8.08 set on Nov 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.71 |
---|---|
High | 17.76 |
Low | 16.50 |
Bid | 17.64 |
Offer | 17.71 |
Previous close | 16.53 |
Average volume | 292.97k |
---|---|
Shares outstanding | 21.16m |
Free float | 19.87m |
P/E (TTM) | -- |
Market cap | 349.71m USD |
EPS (TTM) | -6.56 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 18:44 BST.
More ▼